High Remnant Lipoprotein Predicts Recurrent Cardiovascular Events on Statin Treatment After Acute Coronary Syndrome

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944 · see citing works

Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)

Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011 · see citing works

ACC/AHA Guidelines for the Management of Patients With Unstable Angina and Non–ST-Segment Elevation Myocardial Infarction: Executive Summary and Recommendations

D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Circulation · doi:10.1161/01.cir.102.10.1193 · Cited by 4,474 · see citing works

ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarction

D, E. B. M., Antman, E. M., Beasley, J. W., Califf, R. M., Cheitlin, M. D., Hochman, J. S., Jones, R. H., Kereiakes, D. J., Kupersmith, J., Levin, T. N., et al. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00889-5 · Cited by 954 · see citing works

Standards of Medical Care in Diabetes

(2004) · Diabetes Care · doi:10.2337/diacare.27.2007.s15 · Cited by 684 · see citing works

Impact of triglyceride levels beyond low-density lipoprotein cholesterol after acute coronary syndrome in the PROVE IT-TIMI 22 trial

Miller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., & Braunwald, E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.038 · Cited by 610 · see citing works

Seventh Report of the Joint National Committee on the Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC 7)

Lenfant, C. J. M., Chobanian, A. V., Jones, D. W., & Roccella, E. J. (2003) · Hypertension · doi:10.1161/01.hyp.0000075790.33892.ae · Cited by 583 · see citing works

Executive Summary of the Japan Atherosclerosis Society (JAS) Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases in Japan ^|^mdash;2012 Version

Teramoto, T., Sasaki, J., Ishibashi, S., Birou, S., Daida, H., Dohi, S., Egusa, G., Hiro, T., Hirobe, K., Iida, M., et al. (2013) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.15792 · Cited by 468 · see citing works

Underestimated and under-recognized: the late consequences of acute coronary syndrome (GRACE UK-Belgian Study)

Fox, K. A. A., Carruthers, K. F., Dunbar, D. R., Graham, C., Manning, J. R., RAEDT, H. D., Buysschaert, I., Lambrechts, D., & de Werf, F. V. (2010) · European Heart Journal · doi:10.1093/eurheartj/ehq326 · Cited by 467 · see citing works

Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial

Sabaté, M., Cequier, A. R., Íñiguez, A., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61223-9 · Cited by 462 · see citing works

Cholesterol in remnant-like lipoproteins in human serum using monoclonal anti apo B-100 and anti apo A-I immunoaffinity mixed gels

Nakajima, K., SAITO, T., Tamura, A., Suzuki, M., Nakano, T., Adachi, M., Tanaka, A., Tada, N., Nakamura, H., Campos, E. M., et al. (1993) · Clinica Chimica Acta · doi:10.1016/0009-8981(93)90062-9 · Cited by 417 · see citing works

Remnant Lipoprotein Levels in Fasting Serum Predict Coronary Events in Patients With Coronary Artery Disease

Kugiyama, K., Doi, H., Takazoe, K., Kawano, H., Soejima, H., Mizuno, Y., Tsunoda, R., Sakamoto, T., Nakano, T., Nakajima, K., et al. (1999) · Circulation · doi:10.1161/01.cir.99.22.2858 · Cited by 284 · see citing works

2012 ACCF/AHA Focused Update Incorporated Into the ACCF/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction

Anderson, J. L., Adams, C. D., Antman, E. M., Bridges, C. R., Califf, R. M., Casey, D. E., Chavey, W. E., Fesmire, F. M., Hochman, J. S., Levin, T. N., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31828478ac · Cited by 273 · see citing works

Remnant Lipoproteins Induce Proatherothrombogenic Molecules in Endothelial Cells Through a Redox-Sensitive Mechanism

Doi, H., Kugiyama, K., Oka, H., Sugiyama, S., Ogata, N., Koide, S.-I., Nakamura, S.-I., & Yasue, H. (2000) · Circulation · doi:10.1161/01.cir.102.6.670 · Cited by 227 · see citing works

Adherence to Statin Therapy and LDL Cholesterol Goal Attainment by Patients With Diabetes and Dyslipidemia

Parris, E. S., Lawrence, D. B., Mohn, L. A., & Long, L. B. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.595 · Cited by 155 · see citing works

Evaluation of an immunoseparation method for quantitative measurement of remnant-like particle-cholesterol in serum and plasma

Leary, E. T., Wang, T., Baker, D. J., Cilla, D. D., Zhong, J., Warnick, G. R., Nakajima, K., & Havel, R. J. (1998) · Clinical Chemistry · doi:10.1093/clinchem/44.12.2490 · Cited by 110 · see citing works

Remnant lipoproteins as therapeutic targets

Havel, R. J. (2000) · Current Opinion in Lipidology · doi:10.1097/00041433-200012000-00008 · Cited by 107 · see citing works

Relative Atherogenicity and Predictive Value of Non–High-Density Lipoprotein Cholesterol for Coronary Heart Disease

Miller, M., Ginsberg, H. N., & Schaefer, E. J. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.046 · Cited by 102 · see citing works

Guidelines for Secondary Prevention of Myocardial Infarction (JCS 2011)

JCS Joint Working Group (2012) · Circulation Journal · doi:10.1253/circj.cj-66-0053 · Cited by 92 · see citing works

Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus

Fukushima, H., Sugiyama, S., Honda, O., Koide, S., Nakamura, S., Sakamoto, T., Yoshimura, M., Ogawa, H., Fujioka, D., & Kugiyama, K. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2003.09.074 · Cited by 91 · see citing works

Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.

Nakamura, T., Takano, H., Umetani, K., Kawabata, K.-I., Obata, J.-E., Kitta, Y., Kodama, Y., Mende, A., Ichigi, Y., Fujioka, D., et al. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.01.012 · Cited by 90 · see citing works

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Nakamura, T., Obata, J.-E., Hirano, M., Kitta, Y., Fujioka, D., Saito, Y., Kawabata, K.-I., Watanabe, K., Watanabe, Y., Mishina, H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.040 · Cited by 83 · see citing works

A comparison of the efficacy of combined ezetimibe and statin therapy with doubling of statin dose in patients with remnant lipoproteinemia on previous statin therapy

Nakamura, T., Hirano, M., Kitta, Y., Fujioka, D., Saitō, Y., Kawabata, K., Obata, J., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2012) · Journal of Cardiology · doi:10.1016/j.jjcc.2012.02.005 · Cited by 41 · see citing works

Overcoming inertia: improvement in achieving target low-density lipoprotein cholesterol.

Goldberg, K. C., Melnyk, S. D., & Simel, D. L. (2007) · PubMed · Cited by 39 · see citing works

Gap between guidelines and practice: attainment of treatment targets in patients with primary hypercholesterolemia starting statin therapy. Results of the 4E-Registry (Efficacy Calculation and Measurement of Cardiovascular and Cerebrovascular Events including Physicians' Experience and Evaluation)

Assmann, G., Benecke, H., Neiss, A., Cullen, P., Schulte, H., & Bestehorn, K. P. (2006) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/01.hjr.0000189805.76482.6e · Cited by 36 · see citing works

High serum levels of remnant lipoproteins predict ischemic stroke in patients with metabolic syndrome and mild carotid atherosclerosis

Nakamura, T., Obata, J., Takano, H., Kawabata, K., Sano, K., Kobayashi, T., Fujioka, D., Saitō, Y., Yano, T., & Kugiyama, K. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.03.018 · Cited by 35 · see citing works

Ezetimibe Improves Endothelial Function and Inhibits Rho-Kinase Activity Associated With Inhibition of Cholesterol Absorption in Humans

Nochioka, K., Tanaka, S.-I., Miura, M., Do.e, Z., Fukumoto, Y., Shiba, N., & Shimokawa, H. (2012) · Circulation Journal · doi:10.1253/circj.cj-12-0331 · Cited by 30 · see citing works

Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes

Kazama, H., Usui, S., Okazaki, M., Hosoi, T., Ito, H., & Orimo, H. (2003) · Diabetes Research and Clinical Practice · doi:10.1016/s0168-8227(02)00243-7 · Cited by 25 · see citing works

Trends in Low-Density Lipoprotein Cholesterol Goal Achievement in High Risk United States Adults: Longitudinal Findings from the 1999–2008 National Health and Nutrition Examination Surveys

Tattersall, M. C., Gangnon, R. E., Karmali, K. N., Cullen, M. W., Stein, J. H., & Keevil, J. G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0059309 · Cited by 21 · see citing works

Comparative Study of Bezafibrate and Pravastatin in Patients With Coronary Artery Disease and High Levels of Remnant Lipoprotein

Sano, K., Nakamura, T., Hirano, M., Kitta, Y., Kobayashi, T., Fujioka, D., Saitō, Y., Yano, T., Watanabe, K., Watanabe, Y., et al. (2010) · Circulation Journal · doi:10.1253/circj.cj-10-0079 · Cited by 20 · see citing works

Japan Atherosclerosis Society (JAS) guidelines for prevention of atherosclerotic cardiovascular diseases 2017

Kinoshita, M., Yokote, K., Arai, H., Iida, M., Ishigaki, Y., Ishibashi, S., Umemoto, S., Egusa, G., Ohmura, H., Okamura, T., et al. (2018) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2017 · Cited by 813 · see citing works

Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2022

Okamura, T., Tsukamoto, K., Arai, H., Fujioka, Y., Ishigaki, Y., Koba, S., Ohmura, H., Shoji, T., Yokote, K., Yoshida, H., et al. (2023) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.gl2022 · Cited by 317 · see citing works

Cholesterol Remnants, Triglyceride-Rich Lipoproteins and Cardiovascular Risk

Baratta, F., Cocomello, N., Coronati, M., Ferro, D., Pastori, D., Angelico, F., & Ben, M. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054268 · Cited by 84 · see citing works

Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations

Tada, H., Kawashiri, M., Yoshida, T., Teramoto, R., Nohara, A., Konno, T., Inazu, A., Mabuchi, H., Yamagishi, M., & Hayashi, K. (2015) · Circulation Journal · doi:10.1253/circj.cj-15-0999 · Cited by 78 · see citing works

Remnant Lipoprotein Cholesterol and Cardiovascular and Cerebrovascular Events in Patients with Non-Alcoholic Fatty Liver Disease

Pastori, D., Baratta, F., Novo, M., Cocomello, N., Violi, F., Angelico, F., & Ben, M. D. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110378 · Cited by 59 · see citing works

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies

Ballantyne, C. M., Bays, H. E., Philip, S., Doyle, R. T., Braeckman, R. A., Stirtan, W. G., Soni, P. N., & Juliano, R. A. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.08.005 · Cited by 52 · see citing works

Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome

Sekimoto, T., Koba, S., Mori, H., Sakai, R., Arai, T., Yokota, Y., Sato, S., Tanaka, H., Masaki, R., Oishi, Y., et al. (2021) · Journal of Atherosclerosis and Thrombosis · doi:10.5551/jat.60152 · Cited by 46 · see citing works

Small dense low‐density lipoprotein cholesterol is a promising biomarker for secondary prevention in older men with stable coronary artery disease

Sakai, K., Koba, S., Nakamura, Y., Yokota, Y., Tsunoda, F., Shoji, M., Itoh, Y., Hamazaki, Y., & Kobayashi, Y. (2018) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/ggi.13287 · Cited by 36 · see citing works

Atherogenic Lipoproteins for the Statin Residual Cardiovascular Disease Risk

Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232113499 · Cited by 35 · see citing works

Dysbetalipoproteinemia

MARAIS, D. P. (2015) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000192 · Cited by 33 · see citing works

Residual cardiovascular risk in coronary artery disease: from pathophysiology to established and novel therapies

Galli, M., Abbate, A., Bonaca, M. P., Crea, F., Forte, M., Frati, G., Gaudino, M. F. L., Gibson, C. M., Gorog, D. A., Mehran, R., et al. (2026) · Nature Reviews Cardiology · doi:10.1038/s41569-026-01249-z · Cited by 35 · see citing works

Remnant Cholesterol and Residual Risk of Atherosclerotic Cardiovascular Disease

Li, X., Li, Z.-F., & Wu, N. (2025) · Reviews in Cardiovascular Medicine · doi:10.31083/rcm25985 · Cited by 26 · see citing works

Association of remnant cholesterol and non-high density lipoprotein cholesterol with risk of cardiovascular mortality among US general population

Cheang, I., Zhu, X., Lu, X., Shi, S., Tang, Y., Yue, X., Liao, S., Yao, W., Zhou, Y., Zhang, H., et al. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e10050 · Cited by 23 · see citing works

Differential Effects of Strong and Regular Statins on the Clinical Outcome of Patients With Chronic Kidney Disease Following Coronary Stent Implantation – The Kumamoto Intervention Conference Study (KICS) Registry –

Ishii, M., Hokimoto, S., Akasaka, T., Fujimoto, K., Miyao, Y., Kaikita, K., Oshima, S., Nakao, K., Shimomura, H., Tsunoda, R., et al. (2015) · Circulation Journal · doi:10.1253/circj.cj-14-0789 · Cited by 22 · see citing works

Development of a Novel Homogeneous Assay for Remnant Lipoprotein Particle Cholesterol

Hirao, Y., Nakajima, K., Machida, T., Murakami, M., & Ito, Y. (2018) · The Journal of Applied Laboratory Medicine · doi:10.1373/jalm.2017.024919 · Cited by 21 · see citing works

Prognostic impact of estimated remnant-like particle cholesterol in patients with differing glycometabolic status: an observational cohort study from China

Zhao, Q., Zhang, T., Cheng, Y., Ma, Y., Xu, Y.-K., Yang, J., & Zhou, Y.-J. (2020) · Lipids in Health and Disease · doi:10.1186/s12944-020-01355-y · Cited by 20 · see citing works

Remnant-like particles and coronary artery disease in familial hypercholesterolemia

Tada, H., Kawashiri, M., Nohara, A., Sakata, K., Inazu, A., Mabuchi, H., Yamagishi, M., & Hayashi, K. (2018) · Clinica Chimica Acta · doi:10.1016/j.cca.2018.04.007 · Cited by 19 · see citing works

Association of triglyceride-rich lipoprotein-cholesterol with recurrent cardiovascular events in statin-treated patients according to different inflammatory status

Liu, H., Li, S., Cao, Y., Guo, Y., Zhu, C., Wu, N., & Li, J. (2021) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2021.06.907 · Cited by 18 · see citing works

Remnant-Like Particle Cholesterol and the Risk of Major Adverse Cardiovascular Events: A Systematic Review and Meta-Analysis

Yang, J., Wang, Y., Xi, Z., Ma, Y., Shao, C., Wang, W., & Tang, Y. (2022) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd9120452 · Cited by 17 · see citing works

Cytotoxin-associated gene antigen-positive strains ofHelicobacter pyloriand recurring acute coronary syndromes

Niccoli, G., Roberto, M., D’Amario, D., Scalone, G., Fracassi, F., Cosentino, N., Candelli, M., Franceschi, F., & Crea, F. (2016) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872615627708 · Cited by 17 · see citing works

Lipoprotein(a) is associated with recurrent cardiovascular events in patients with coronary artery disease and prediabetes or diabetes

He, J., Yang, M.-F., Song, C., Zhang, R., Yuan, S., Li, J., & Dou, K. (2023) · Journal of Endocrinological Investigation · doi:10.1007/s40618-023-02203-3 · Cited by 13 · see citing works

Impact of nonfasting triglycerides/high-density lipoprotein cholesterol ratio on secondary prevention in patients treated with statins

Matsumoto, I., Misaki, A., Kurozumi, M., Nanba, T., & Takagi, Y. (2017) · Journal of Cardiology · doi:10.1016/j.jjcc.2017.07.012 · Cited by 13 · see citing works

Effect of coronary artery spasm on long-term outcomes in survivors of acute myocardial infarction

Deyama, J., Nakamura, T., Saitō, Y., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.08.002 · Cited by 12 · see citing works

A significant presence in atherosclerotic cardiovascular disease: Remnant cholesterol: A review

Wang, L., Zhang, Q., Wu, Z., & Huang, X. (2024) · Medicine · doi:10.1097/md.0000000000038754 · Cited by 13 · see citing works

Predictive value of small dense low-density lipoprotein cholesterol for cardiovascular events in Chinese elder diabetes mellitus patients

Xu, L., Chen, X., Lu, J., Xu, Y., Yang, H., Zhou, X., Zhou, J., Xu, J., & Shen, H. (2021) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-021-00667-y · Cited by 6 · see citing works

Elevated remnant cholesterol as a potential predictor for cardiovascular events in rheumatoid arthritis patients

Chang, C., Li, Y., Chen, P., Chang, S.-H., & Chen, D. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1449219 · Cited by 5 · see citing works

Managing Residual Risk After Myocardial Infarction Among Individuals with Low Cholesterol Levels

Colantonio, L. D., & Bittner, V. (2016) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.09.011 · Cited by 5 · see citing works

Managing Residual Risk After Myocardial Infarction Among Individuals with Low Cholesterol Levels

Colantonio, L. D., & Bittner, V. (2015) · Cardiology Clinics · doi:10.1016/j.ccl.2015.01.004 · Cited by 3 · see citing works

Prognostic value of remnant-like particle cholesterol in ischemic heart failure patients following percutaneous coronary intervention

Huang, X., Sun, T., Zhang, B., Ma, M., Chen, Z., Zhao, Z., Dong, S., & Zhou, Y. (2025) · Annals of Medicine · doi:10.1080/07853890.2025.2458200 · Cited by 2 · see citing works

Impact of remnant cholesterol on short-term mortality in acute decompensated heart failure: cohort study evidence from Jiangxi, China

Jian, G., Jiang, K., Lu, Z., He, S., Xie, L., Zhang, S., Wang, Q., Lu, H., Xiong, Z., Wu, Z., et al. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1624112 · Cited by 2 · see citing works

Elevated Remnant Lipoprotein Related to Adverse Events in Patients with Chronic Limb-Threatening Ischemia after Endovascular Therapy for Below-the-Knee Lesions

Ito, N., Hishikari, K., Yoshikawa, H., Yano, H., Iiya, M., Murai, T., Hikita, H., Takahashi, A., Yonetsu, T., & Sasano, T. (2022) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2022.01.024 · Cited by 1 · see citing works

Prognostic Impact of Remnant-like Particle Cholesterol in Patients with Differing Glucose Metabolic Status: an Observational Cohort Study from ChinaPreprint

Zhao, Q., Zhang, T., Cheng, Y., Ma, Y., Xu, Y.-K., Yang, J., & Zhou, Y. (2020) · doi:10.21203/rs.3.rs-33302/v1

The Relationship between Residual Cholesterol and Acute Myocardial Infarction in Patients with Type 2 Diabetes

韩, 晓. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.131103

Managing remnant cholesterol: role of fenofibrate–statin therapy in reducing triglyceride-rich lipoproteins

Raja, V., Aguiar, C. A., Alsayed, N., Chibber, Y. S., ElBadawi, H., Farnier, M., Pushpa, K., Tokgözoğlu, L. S., Zambon, A., Berrou, J., et al. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1837004

Remnant Lipoproteins Are Residual Risk Factor for Future Cardiovascular Events in Patients With Stable Coronary Artery Disease and On-Statin Low-Density Lipoprotein Cholesterol Levels <70 mg/dL

Fujihara, Y., Nakamura, T., Horikoshi, T., Obata, J., Fujioka, D., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2019) · Circulation Journal · doi:10.1253/circj.cj-19-0047 · Cited by 52 · see citing works

Predictive value of remnant lipoprotein for cardiovascular events in patients with coronary artery disease after achievement of LDL-cholesterol goals

Nakamura, T., Obata, J.-E., Hirano, M., Kitta, Y., Fujioka, D., Saito, Y., Kawabata, K.-I., Watanabe, K., Watanabe, Y., Mishina, H., et al. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.04.040 · Cited by 83 · see citing works

Impact of Lipoprotein(a) as a Residual Risk Factor in Long-Term Cardiovascular Outcomes in Patients With Acute Coronary Syndrome Treated With Statins

Takahashi, D., Wada, H., Ogita, M., Yasuda, K., Nishio, R., Takeuchi, M., Shitara, J., Tsuboi, S., Dohi, T., Suwa, S., et al. (2022) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2021.12.014 · Cited by 26 · see citing works

P1227Remnant lipoprotein is a residual risk of future cardiovascular events in patients with stable coronary artery disease and on statin LDL-cholesterol levels less than 70 mg/dl

Fujihara, Y., Nakamura, T., Horikoshi, T., Obata, J., Fujioka, D., Watanabe, Y., Watanabe, K., & Kugiyama, K. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz748.0185

Impact of lipoprotein(a) as a residual risk on long-term cardiovascular outcomes in patients with acute coronary syndrome treated with statin

Takahashi, D., Wada, H., Ogita, M., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab724.1321